FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:325-334 August 2, 2001 Number 5 Next

	Full Text PDF Editorial by Loscalzo, J. Editorial by Welch, C. A. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Most patients with familial primary pulmonary hypertension have defects in the gene for bone morphogenetic protein receptor II (BMPR2), a member of the transforming growth factor (TGF-) superfamily of receptors. Because patients with hereditary hemorrhagic telangiectasia may have lung disease that is indistinguishable from primary pulmonary hypertension, we investigated the genetic basis of lung disease in these patients.

Methods We evaluated members of five kindreds plus one individual patient with hereditary hemorrhagic telangiectasia and identified 10 cases of pulmonary hypertension. In the two largest families, we used microsatellite markers to test for linkage to genes encoding TGF-–receptor proteins, including endoglin and activin-receptor–like kinase 1 (ALK1), and BMPR2. In subjects with hereditary hemorrhagic telangiectasia and pulmonary hypertension, we also scanned ALK1 and BMPR2 for mutations.

Results We identified suggestive linkage of pulmonary hypertension with hereditary hemorrhagic telangiectasia on chromosome 12q13, a region that includes ALK1. We identified amino acid changes in activin-receptor–like kinase 1 that were inherited in subjects who had a disorder with clinical and histologic features indistinguishable from those of primary pulmonary hypertension. Immunohistochemical analysis in four subjects and one control showed pulmonary vascular endothelial expression of activin-receptor–like kinase 1 in normal and diseased pulmonary arteries.

Conclusions Pulmonary hypertension in association with hereditary hemorrhagic telangiectasia can involve mutations in ALK1. These mutations are associated with diverse effects, including the vascular dilatation characteristic of hereditary hemorrhagic telangiectasia and the occlusion of small pulmonary arteries that is typical of primary pulmonary hypertension.

Source Information

From the Division of Medical Genetics, Departments of Medicine and Genetics, University of Leicester, Leicester, United Kingdom (R.C.T., J.R.T., R.D.M., N.V.M.); the Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's and Papworth Hospitals, Cambridge, United Kingdom (C.A., N.W.M.); the Department of Molecular Medicine, School of Medicine, University of Auckland, Auckland, New Zealand (I.W.); the Service de Pneumologie, Hôpital Antoine Béclère, Assistance Publique–Hôpitaux de Paris, Université Paris-Sud, Clamart, France (G.S., M.H.); the Institute of Cardiology, University of Bologna, Bologna, Italy (N.G.); Vanderbilt University Medical Center, Nashville (J.E.L.); and the Division of Human Genetics, Children's Hospital Medical Center, Cincinnati (W.C.N.).

Other authors were Jonathan Berg, M.D., Department of Clinical Genetics, Guy's Hospital Campus, King's College, London; Alessandra Manes, M.D., Institute of Cardiology, University of Bologna, Bologna, Italy; Julie McGaughran, M.D., Department of Molecular Medicine, School of Medicine, University of Auckland, Auckland, New Zealand; Michael Pauciulo, B.Sc., Division of Human Genetics, Children's Hospital Medical Center, Cincinnati; and Lisa Wheeler, B.Sc., Vanderbilt University Medical Center, Nashville.

Address reprint requests to Dr. Trembath at the Division of Medical Genetics, Departments of Medicine and Genetics, Adrian Bldg., University of Leicester, Leicester LE1 7RH, United Kingdom, or at rtrembat{at}hgmp.mrc.ac.uk.

Full Text of this Article

This article has been cited by other articles:

• Tipps, R. S., Mumtaz, M., Leahy, P., Duncan, B. W. (2008). Gene array analysis of a rat model of pulmonary arteriovenous malformations after superior cavopulmonary anastomosis.. J. Thorac. Cardiovasc. Surg. 136: 283-289 [Abstract] [Full Text]  
• Hoeper, M. M., Humbert, M. (2008). A message on the lips. Eur Respir J 32: 15-16 [Full Text]  
• Shovlin, C. L., Tighe, H. C., Davies, R. J., Gibbs, J. S. R., Jackson, J. E. (2008). Embolisation of pulmonary arteriovenous malformations: no consistent effect on pulmonary artery pressure. Eur Respir J 32: 162-169 [Abstract] [Full Text]  
• Lu, Q. (2008). Transforming growth factor-{beta}1 protects against pulmonary artery endothelial cell apoptosis via ALK5. Am. J. Physiol. Lung Cell. Mol. Physiol. 295: L123-L133 [Abstract] [Full Text]  
• Haworth, S G (2008). The management of pulmonary hypertension in children. Arch. Dis. Child. 93: 620-625 [Abstract] [Full Text]  
• Ashley-Koch, A. E., Elliott, L., Kail, M. E., De Castro, L. M., Jonassaint, J., Jackson, T. L., Price, J., Ataga, K. I., Levesque, M. C., Weinberg, J. B., Orringer, E. P., Collins, A., Vance, J. M., Telen, M. J. (2008). Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease. Blood 111: 5721-5726 [Abstract] [Full Text]  
• David, L., Mallet, C., Keramidas, M., Lamande, N., Gasc, J.-M., Dupuis-Girod, S., Plauchu, H., Feige, J.-J., Bailly, S. (2008). Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence Factor. Circ. Res. 102: 914-922 [Abstract] [Full Text]  
• National Pulmonary Hypertension Centres of the UK, (2008). Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland. Heart 94: i1-i41 [Full Text]  
• National Pulmonary Hypertension Centres of the UK, (2008). Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland. Thorax 63: ii1-ii41 [Full Text]  
• Newman, J. H., Phillips, J. A. III, Loyd, J. E. (2008). Narrative Review: The Enigma of Pulmonary Arterial Hypertension: New Insights from Genetic Studies. ANN INTERN MED 148: 278-283 [Abstract] [Full Text]  
• SWANSON, K. L., KROWKA, M. J. (2008). Screen for portopulmonary hypertension, especially in liver transplant candidates. Cleveland Clinic Journal of Medicine 75: 121-136 [Abstract] [Full Text]  
• Frank, D. B., Lowery, J., Anderson, L., Brink, M., Reese, J., de Caestecker, M. (2008). Increased susceptibility to hypoxic pulmonary hypertension in Bmpr2 mutant mice is associated with endothelial dysfunction in the pulmonary vasculature. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L98-L109 [Abstract] [Full Text]  
• Aldred, M. A., Machado, R. D., James, V., Morrell, N. W., Trembath, R. C. (2007). Characterization of the BMPR2 5'-Untranslated Region and a Novel Mutation in Pulmonary Hypertension. Am. J. Respir. Crit. Care Med. 176: 819-824 [Abstract] [Full Text]  
• Liu, D., Wang, J., Kinzel, B., Mueller, M., Mao, X., Valdez, R., Liu, Y., Li, E. (2007). Dosage-dependent requirement of BMP type II receptor for maintenance of vascular integrity. Blood 110: 1502-1510 [Abstract] [Full Text]  
• Tidswell, M., Higgins, T. L. (2007). The Anesthesiologist and Pulmonary Arterial Hypertension. SEMIN CARDIOTHORAC VASC ANESTH 11: 93-95  
• Zakrzewicz, A., Kouri, F. M., Nejman, B., Kwapiszewska, G., Hecker, M., Sandu, R., Dony, E., Seeger, W., Schermuly, R. T., Eickelberg, O., Morty, R. E. (2007). The transforming growth factor-{beta}/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension. Eur Respir J 29: 1094-1104 [Abstract] [Full Text]  
• Perros, F., Dorfmuller, P., Souza, R., Durand-Gasselin, I., Godot, V., Capel, F., Adnot, S., Eddahibi, S., Mazmanian, M., Fadel, E., Herve, P., Simonneau, G., Emilie, D., Humbert, M. (2007). Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension. Eur Respir J 29: 937-943 [Abstract] [Full Text]  
• Minai, O. A., Rigelsky, C., Eng, C., Arroliga, A. C., Stoller, J. K. (2007). Long-term Outcome in a Patient With Pulmonary Hypertension and Hereditary Hemorrhagic Telangiectasia. Chest 131: 984-987 [Abstract] [Full Text]  
• Gedge, F., McDonald, J., Phansalkar, A., Chou, L.-S., Calderon, F., Mao, R., Lyon, E., Bayrak-Toydemir, P. (2007). Clinical and Analytical Sensitivities in Hereditary Hemorrhagic Telangiectasia Testing and a Report of de Novo Mutations. J. Mol. Diagn. 9: 258-265 [Abstract] [Full Text]  
• McMurtry, M. S., Moudgil, R., Hashimoto, K., Bonnet, S., Michelakis, E. D., Archer, S. L. (2007). Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L872-L878 [Abstract] [Full Text]  
• Boyer, D., Westra, S. J., Kinane, T. B., Stone, J. R. (2007). Case 3-2007 -- A 3-Year-Old Boy with Recurrent Episodes of Respiratory Insufficiency. NEJM 356: 398-407 [Full Text]  
• (2006). Poster presentations. Thorax 61: ii57-ii133 [Full Text]  
• Morrell, N. W. (2006). Pulmonary Hypertension Due to BMPR2 Mutation: A New Paradigm for Tissue Remodeling?. Proc Am Thorac Soc 3: 680-686 [Abstract] [Full Text]  
• Ghofrani, H. A., Voswinckel, R., Reichenberger, F., Weissmann, N., Schermuly, R. T., Seeger, W., Grimminger, F. (2006). Hypoxia- and non-hypoxia-related pulmonary hypertension - Established and new therapies. Cardiovasc Res 72: 30-40 [Abstract] [Full Text]  
• McLaughlin, V. V., McGoon, M. D. (2006). Pulmonary Arterial Hypertension. Circulation 114: 1417-1431 [Full Text]  
• Hoeper, M. M., Rubin, L. J. (2006). Update in pulmonary hypertension 2005.. Am. J. Respir. Crit. Care Med. 173: 499-505 [Full Text]  
• Fernandez-L, A., Sanz-Rodriguez, F., Blanco, F. J., Bernabeu, C., Botella, L. M. (2006). Hereditary Hemorrhagic Telangiectasia, a Vascular Dysplasia Affecting the TGF-{beta} Signaling Pathway.. Clin Med Res 4: 66-78 [Abstract] [Full Text]  
• Gu, Y., Jin, P., Zhang, L., Zhao, X., Gao, X., Ning, Y., Meng, A., Chen, Y.-G. (2006). Functional analysis of mutations in the kinase domain of the TGF-beta receptor ALK1 reveals different mechanisms for induction of hereditary hemorrhagic telangiectasia. Blood 107: 1951-1954 [Abstract] [Full Text]  
• Abdalla, S A, Letarte, M (2006). Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J. Med. Genet. 43: 97-110 [Abstract] [Full Text]  
• Rubin, L. J. (2006). Pulmonary arterial hypertension.. Proc Am Thorac Soc 3: 111-115 [Abstract] [Full Text]  
• Mouthon, L., Guillevin, L., Humbert, M. (2005). Pulmonary arterial hypertension: an autoimmune disease?. Eur Respir J 26: 986-988 [Full Text]  
• Bertolino, P., Deckers, M., Lebrin, F., ten Dijke, P. (2005). Transforming Growth Factor-{beta} Signal Transduction in Angiogenesis and Vascular Disorders. Chest 128: 585S-590S [Abstract] [Full Text]  
• Bertolino, P., Deckers, M., Lebrin, F., ten Dijke, P. (2005). Transforming Growth Factor-{beta} Signal Transduction in Angiogenesis and Vascular Disorders. Chest 128: 585S-590S [Abstract] [Full Text]  
• Zaiman, A., Fijalkowska, I., Hassoun, P. M., Tuder, R. M. (2005). One Hundred Years of Research in the Pathogenesis of Pulmonary Hypertension. Am. J. Respir. Cell Mol. Bio. 33: 425-431 [Full Text]  
• Wong, W. K. P., Knowles, J. A., Morse, J. H. (2005). Bone Morphogenetic Protein Receptor Type II C-Terminus Interacts with c-Src: Implication for a Role in Pulmonary Arterial Hypertension. Am. J. Respir. Cell Mol. Bio. 33: 438-446 [Abstract] [Full Text]  
• Newman, J. H. (2005). Pulmonary Hypertension. Am. J. Respir. Crit. Care Med. 172: 1072-1077 [Abstract] [Full Text]  
• Tamby, M C, Chanseaud, Y, Humbert, M, Fermanian, J, Guilpain, P, Garcia-de-la-Pena-Lefebvre, P, Brunet, S, Servettaz, A, Weill, B., Simonneau, G, Guillevin, L, Boissier, M C, Mouthon, L (2005). Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax 60: 765-772 [Abstract] [Full Text]  
• Adatia, I. (2005). Improving the Outcome of Childhood Pulmonary Arterial Hypertension: The Effect of Bosentan in the Setting of a Dedicated Pulmonary Hypertension Clinic. J Am Coll Cardiol 46: 705-706 [Full Text]  
• Cole, S G, Begbie, M E, Wallace, G M F, Shovlin, C L (2005). A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J. Med. Genet. 42: 577-582 [Abstract] [Full Text]  
• Herrick, A. L. (2005). Pathogenesis of Raynaud's phenomenon. Rheumatology (Oxford) 44: 587-596 [Abstract] [Full Text]  
• Harrison, R. E., Berger, R., Haworth, S. G., Tulloh, R., Mache, C. J., Morrell, N. W., Aldred, M. A., Trembath, R. C. (2005). Transforming Growth Factor-{beta} Receptor Mutations and Pulmonary Arterial Hypertension in Childhood. Circulation 111: 435-441 [Abstract] [Full Text]  
• Satoh, T., Kimura, K., Okano, Y., Hirakata, M., Kawakami, Y., Kuwana, M. (2005). Lack of circulating autoantibodies to bone morphogenetic protein receptor-II or activin receptor-like kinase 1 in mixed connective tissue disease patients with pulmonary arterial hypertension. Rheumatology (Oxford) 44: 192-196 [Abstract] [Full Text]  
• Task Force members, , Galie, N., Torbicki, A., Barst, R., Dartevelle, P., Haworth, S., Higenbottam, T., Olschewski, H., Peacock, A., Pietra, G., Rubin, L. J., Simonneau, G. (2004). Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25: 2243-2278 [Full Text]  
• Beppu, H., Ichinose, F., Kawai, N., Jones, R. C., Yu, P. B., Zapol, W. M., Miyazono, K., Li, E., Bloch, K. D. (2004). BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 287: L1241-L1247 [Abstract] [Full Text]  
• Rodriguez-Roisin, R., Krowka, M.J., Herve, Ph., Fallon, M.B., on behalf of the ERS Task Force Pulmonary-Hepatic, (2004). Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J 24: 861-880 [Full Text]  
• Farber, H. W., Loscalzo, J. (2004). Pulmonary Arterial Hypertension. NEJM 351: 1655-1665 [Full Text]  
• Takeda, M., Otsuka, F., Nakamura, K., Inagaki, K., Suzuki, J., Miura, D., Fujio, H., Matsubara, H., Date, H., Ohe, T., Makino, H. (2004). Characterization of the Bone Morphogenetic Protein (BMP) System in Human Pulmonary Arterial Smooth Muscle Cells Isolated from a Sporadic Case of Primary Pulmonary Hypertension: Roles of BMP Type IB Receptor (Activin Receptor-Like Kinase-6) in the Mitotic Action. Endocrinology 145: 4344-4354 [Abstract] [Full Text]  
• Doherty, T. M., Fitzpatrick, L. A., Inoue, D., Qiao, J.-H., Fishbein, M. C., Detrano, R. C., Shah, P. K., Rajavashisth, T. B. (2004). Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification. Endocr. Rev. 25: 629-672 [Abstract] [Full Text]  
• McGoon, M., Gutterman, D., Steen, V., Barst, R., McCrory, D. C., Fortin, T. A., Loyd, J. E. (2004). Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines. Chest 126: 14S-34S [Abstract] [Full Text]  
• Newman, J. H., Fanburg, B. L., Archer, S. L., Badesch, D. B., Barst, R. J., Garcia, J. G.N., Kao, P. N., Knowles, J. A., Loyd, J. E., McGoon, M. D., Morse, J. H., Nichols, W. C., Rabinovitch, M., Rodman, D. M., Stevens, T., Tuder, R. M., Voelkel, N. F., Gail, D. B. (2004). Pulmonary Arterial Hypertension: Future Directions: Report of a National Heart, Lung and Blood Institute/Office of Rare Diseases Workshop. Circulation 109: 2947-2952 [Full Text]  
• Simonneau, G., Galie, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., Rich, S., Fishman, A. (2004). Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43: 5S-12S [Abstract] [Full Text]  
• Humbert, M., Morrell, N. W., Archer, S. L., Stenmark, K. R., MacLean, M. R., Lang, I. M., Christman, B. W., Weir, E. K., Eickelberg, O., Voelkel, N. F., Rabinovitch, M. (2004). Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43: 13S-24S [Abstract] [Full Text]  
• Newman, J. H., Trembath, R. C., Morse, J. A., Grunig, E., Loyd, J. E., Adnot, S., Coccolo, F., Ventura, C., Phillips, J. A. III, Knowles, J. A., Janssen, B., Eickelberg, O., Eddahibi, S., Herve, P., Nichols, W. C., Elliott, G. (2004). Genetic basis of pulmonary arterial hypertension: Current understanding and future directions. J Am Coll Cardiol 43: 33S-39S [Abstract] [Full Text]  
• Chaouat, A, Coulet, F, Favre, C, Simonneau, G, Weitzenblum, E, Soubrier, F, Humbert, M (2004). Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension. Thorax 59: 446-448 [Abstract] [Full Text]  
• Jones, J. E., Walker, J. L., Song, Y., Weiss, N., Cardoso, W. V., Tuder, R. M., Loscalzo, J., Zhang, Y.-Y. (2004). Effect of 5-lipoxygenase on the development of pulmonary hypertension in rats. Am. J. Physiol. Heart Circ. Physiol. 286: H1775-H1784 [Abstract] [Full Text]  
• Abdalla, S.A., Gallione, C.J., Barst, R.J., Horn, E.M., Knowles, J.A., Marchuk, D.A., Letarte, M., Morse, J.H. (2004). Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia. Eur Respir J 23: 373-377 [Abstract] [Full Text]  
• Budhiraja, R., Tuder, R. M., Hassoun, P. M. (2004). Endothelial Dysfunction in Pulmonary Hypertension. Circulation 109: 159-165 [Full Text]  
• Harrison, R E, Flanagan, J A, Sankelo, M, Abdalla, S A, Rowell, J, Machado, R D, Elliott, C G, Robbins, I M, Olschewski, H, McLaughlin, V, Gruenig, E, Kermeen, F, Laitinen, T, Morrell, N W, Trembath, R C (2003). Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia. J. Med. Genet. 40: 865-871 [Abstract] [Full Text]  
• Dorfmuller, P., Perros, F., Balabanian, K., Humbert, M. (2003). Inflammation in pulmonary arterial hypertension. Eur Respir J 22: 358-363 [Abstract] [Full Text]  
• Abdalla, S A, Geisthoff, U W, Bonneau, D, Plauchu, H, McDonald, J, Kennedy, S, Faughnan, M E, Letarte, M (2003). Visceral manifestations in hereditary haemorrhagic telangiectasia type 2. J. Med. Genet. 40: 494-502 [Abstract] [Full Text]  
• Mata-Greenwood, E., Meyrick, B., Steinhorn, R. H., Fineman, J. R., Black, S. M. (2003). Alterations in TGF-{beta}1 expression in lambs with increased pulmonary blood flow and pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L209-L221 [Abstract] [Full Text]  
• Rindermann, M., Grunig, E., von Hippel, A., Koehler, R., Miltenberger-Miltenyi, G., Mereles, D., Arnold, K., Pauciulo, M., Nichols, W., Olschewski, H., Hoeper, M. M., Winkler, J.o., Katus, H. A., Kubler, W., Bartram, C. R., Janssen, B. (2003). Primary pulmonary hypertension may be a heterogeneous disease with a second locus on chromosome 2q31. J Am Coll Cardiol 41: 2237-2244 [Abstract] [Full Text]  
• Marchuk, D. A., Srinivasan, S., Squire, T. L., Zawistowski, J. S. (2003). Vascular morphogenesis: tales of two syndromes. Hum Mol Genet 12: R97-112 [Abstract] [Full Text]  
• van den Driesche, S., Mummery, C. L., Westermann, C. J.J. (2003). Hereditary hemorrhagic telangiectasia: an update on transforming growth factor {beta} signaling in vasculogenesis and angiogenesis. Cardiovasc Res 58: 20-31 [Abstract] [Full Text]  
• Runo, J. R., Vnencak-Jones, C. L., Prince, M., Loyd, J. E., Wheeler, L., Robbins, I. M., Lane, K. B., Newman, J. H., Johnson, J., Nichols, W. C., Phillips, J. A. III (2003). Pulmonary Veno-occlusive Disease Caused by an Inherited Mutation in Bone Morphogenetic Protein Receptor II. Am. J. Respir. Crit. Care Med. 167: 889-894 [Abstract] [Full Text]  
• Srinivasan, S., Hanes, M. A., Dickens, T., Porteous, M. E. M., Oh, S. P., Hale, L. P., Marchuk, D. A. (2003). A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. Hum Mol Genet 12: 473-482 [Abstract] [Full Text]  
• Morse, J H (2003). Genetic studies of pulmonary arterial hypertension. Lupus 12: 209-212 [Abstract]  
• Du, L., Sullivan, C. C., Chu, D., Cho, A. J., Kido, M., Wolf, P. L., Yuan, J. X.-J., Deutsch, R., Jamieson, S. W., Thistlethwaite, P. A. (2003). Signaling Molecules in Nonfamilial Pulmonary Hypertension. NEJM 348: 500-509 [Abstract] [Full Text]  
• Begbie, M E, Wallace, G M F, Shovlin, C L (2003). Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Postgrad. Med. J. 79: 18-24 [Abstract] [Full Text]  
• Lamouille, S., Mallet, C., Feige, J.-J., Bailly, S. (2002). Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 100: 4495-4501 [Abstract] [Full Text]  
• Eddahibi, S., Morrell, N., d'Ortho, M-P., Naeije, R., Adnot, S. (2002). Pathobiology of pulmonary arterial hypertension. Eur Respir J 20: 1559-1572 [Abstract] [Full Text]  
• Loyd, J. E. (2002). Genetics and Pulmonary Hypertension. Chest 122: 284S-286S [Abstract] [Full Text]  
• Humbert, M., Trembath, R.C. (2002). Genetics of pulmonary hypertension: from bench to bedside. Eur Respir J 20: 741-749 [Abstract] [Full Text]  
• Harris, S.E., Chand, A.L., Winship, I.M., Gersak, K., Aittomaki, K., Shelling, A.N. (2002). Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol Hum Reprod 8: 729-733 [Abstract] [Full Text]  
• Humbert, M., Labrune, P., Sitbon, O., Le Gall, C., Callebert, J., Herve, P., Samuel, D., Machado, R., Trembath, R., Drouet, L., Launay, J-M., Simonneau, G. (2002). Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis. Eur Respir J 20: 59-65 [Abstract] [Full Text]  
• Olivieri, C, Mira, E, Delu, G, Pagella, F, Zambelli, A, Malvezzi, L, Buscarini, E, Danesino, C (2002). Identification of 13 new mutations in the ACVRL1 gene in a group of 52 unselected Italian patients affected by hereditary haemorrhagic telangiectasia. J. Med. Genet. 39: e39-39 [Full Text]  
• Balabanian, K., Foussat, A., Dorfmuller, P., Durand-Gasselin, I., Capel, F., Bouchet-Delbos, L., Portier, A., Marfaing-Koka, A., Krzysiek, R., Rimaniol, A.-C., Simonneau, G., Emilie, D., Humbert, M. (2002). CX3C Chemokine Fractalkine in Pulmonary Arterial Hypertension. Am. J. Respir. Crit. Care Med. 165: 1419-1425 [Abstract] [Full Text]  
• Newman, J. H. (2002). Treatment of Primary Pulmonary Hypertension -- The Next Generation. NEJM 346: 933-935 [Full Text]  
• Morse, J. H. (2002). Bone Morphogenetic Protein Receptor 2 Mutations in Pulmonary Hypertension. Chest 121: 50S-53S [Abstract] [Full Text]  
• DORFMULLER, P., ZARKA, V., DURAND-GASSELIN, I., MONTI, G., BALABANIAN, K., GARCIA, G., CAPRON, F., COULOMB-LHERMINE, A., MARFAING-KOKA, A., SIMONNEAU, G., EMILIE, D., HUMBERT, M. (2002). Chemokine RANTES in Severe Pulmonary Arterial Hypertension. Am. J. Respir. Crit. Care Med. 165: 534-539 [Abstract] [Full Text]  
• Rudarakanchana, N, Trembath, R C, Morrell, N W (2001). New insights into the pathogenesis and treatment of primary pulmonary hypertension. Thorax 56: 888-890 [Full Text]  
• Loscalzo, J. (2001). Genetic Clues to the Cause of Primary Pulmonary Hypertension. NEJM 345: 367-371 [Full Text]  
• Welch, C. A. (2001). Sacred Secrets -- The Privacy of Medical Records. NEJM 345: 371-372 [Full Text]